Human Vaccines Project
Script error: No such module "AfC submission catcheck".
The Human Vaccines Project (HuVaP) is a New York City-based 501(c)(3) tax-exempt US organisation. Its stated aims are to harness "the enormous potential of artificial intelligence" in order to "conquer one of the greatest remaining frontiers of human health—the immune system."[1][2] It is twinned with the Stichting Human Vaccines Project Europe, a Netherlands-based foundation funded by the European Union.[3]
History[edit]
The HuVap was strongly supported from its birth by the Bill and Melinda Gates Foundation and the International AIDS Vaccine Initiative.[4][5][6]
The HuVaP was projected as early as 2014, in a Nature paper by Wayne Koff, Ian Gust and Stanley Plotkin.[4][5]
In 2015, the HuVaP partnered with MedImmune, "the worldwide biologics research and development arm of AstraZeneca", to help accelerate research and development in infectious disease and oncology.[6]
In 2016, the HuVaP partnered with Pfizer to "decode the human immune system". They joined "an influential group of peers and research institutions like Regeneron, GlaxoSmithKline, Sanofi Pasteur and Janssen Pharmaceuticals.[7][8]
References[edit]
- ↑ "A NEW APPROACH TO FIGHTING DISEASE". Human Vaccines Project. Retrieved 3 April 2021.
- ↑ Rogers, Adam (24 April 2020). "Want a New Covid-19 Drug Fast? Bring on the Battle Royale". Condé Nast. Wired Magazine.
- ↑ "Name: Stichting Human Vaccines Project Europe" (PDF). Human Vaccines Project. January 2020.
- ↑ 4.0 4.1 Koff, Wayne C.; Gust, Ian D.; Plotkin, Stanley A. (2014). "Toward a Human Vaccines Project". Nature Immunology. 15 (7): 589–592. doi:10.1038/ni.2871. PMID 24940943. Unknown parameter
|s2cid=ignored (help) - ↑ 5.0 5.1 "Toward a Human Vaccines Project: Breaking New Ground in a Collective Search for Vaccines against Major Killer Diseases" (International AIDS Vaccine Initiative). Cision US Inc. PR Newswire. 18 June 2014.
- ↑ 6.0 6.1 "Human Vaccines Project Partners with MedImmune to Help Accelerate Research and Development in Infectious Disease and Oncology" (International AIDS Vaccine Initiative). Cision US Inc. PR Newswire. 13 October 2015.
- ↑ Sagonowsky, Eric (23 March 2016). "Spotlight On... Pfizer joins Human Vaccines Project; PATH to open 'Center for Vaccine Innovation and Access' with $11M Gates Foundation grant; Cadila shares suffer on WHO plant inspection report; and more…". Questex LLC. Fierce Pharma.
- ↑ "Pfizer Joins The Human Vaccines Project To Help Decode The Immune System: By Pooling Knowledge and Resources From Academia, Government, and Industry Partners, the Consortium Will Evaluate Human Immune Responses with the Goal to Potentially Speed Vaccines and Immunotherapeutic Development". Business Wire, Inc, a Berkshire Hathaway Company. 22 March 2016.
This article "Human Vaccines Project" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Human Vaccines Project. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
